Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 624 results found. Search for [ Oxford-Astrazeneca COVID-19 vaccine ]

Results 1 to 21 of 624
PTI
April 16, 2021
The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after Covid-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s


Reuters
April 15, 2021
The United Kingdom launched its inoculation drive in December and has already offered a first shot to all over-50s, the clinically vulnerable and health workers


BusinessToday.In
April 14, 2021
Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.


BusinessToday.In
April 14, 2021
A total of 82,339 patients were discharged in the past 24 hours. As of April 14, India's total case tally stands at 1.38 crore; total recoveries 1.2 crore; active cases 13.6 lakh; and 1.72 lakh patients have died


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


PB Jayakumar
April 9, 2021
WHO Global Advisory Committee on Vaccine Safety said in an interim statement the relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible, but is not confirmed


Reuters
April 9, 2021
The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would \"very shortly apply for permission to conduct clinical bridging trials in India,\" according to the report


PTI
April 9, 2021
Despite increased demand for COVID-19 vaccines in India COVAX expects to deliver doses to all participating economies that have requested vaccines in the first half of the year


Rashi Bisaria
New Delhi, April 9, 2021
Australia, Philippines, African Union ban AstraZeneca's COVID-19 shotAustralia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III tria...


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PTI
April 9, 2021
A growing number of countries have either halted or limited the use of the AstraZeneca coronavirus vaccine recently over fears that it can cause serious blood clots


Reuters
April 9, 2021
The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found rare cases of blood clots among some adult recipients, although it still believes that the vaccine's benefits outweighed its risks


BusinessToday.In
April 8, 2021
The COVID-19 sub-committee of WHO GACVS met on Wednesday to review the recent information from the British, EMA, and other medicines regulators


Rashi Bisaria
New Delhi, April 7, 2021
Oxford-AstraZeneca pauses COVID-19 vaccine trial in children The University of Oxford said on Tuesday it had paused a small UK trial testing the Covid-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the shot. The trial disruption is the latest blow to the vaccine, once hailed as a milestone in the fight against the pandemic IMF raises India's growth forecast for FY22 to 12.5% Internat...


Reuters
April 7, 2021
The European Medicines Agency (EMA) is currently reviewing reports of an extremely rare brain blood clot known as cerebral venous sinus thrombosis (CVST) after the AstraZeneca shots


BusinessToday.In
April 6, 2021
Adar says Covishield has found an excellent response below the age of 50 with one dose. About 70 per cent of people are fully protected with one dose, but the second dose is necessary for long-term immunity protection, he adds


PTI
April 5, 2021
The second phase will begin from Wednesday, April 7. The 800,000 doses of the China manufactured vaccine - Vero Cell- against COVID-19 infection will be administered to the frontline workers as well as those involved in trans-Himalayan trade activities


PTI
April 4, 2021
The pilot schemes involving what is being dubbed as 'Covid-status certification' will include the football FA Cup final at Wembley Stadium in London and are expected to involve a smartphone app or a paper certificate


Reuters
April 3, 2021
Australia launched mass vaccinations for its 25 million people in February, with most expected to receive the University of Oxford/AstraZeneca vaccine, as 50 million doses are being produced domestically by CSL Ltd


PAGES 1 OF 32  12345